AOD-9604 is a research compound. It is not approved by the FDA or any regulatory body for human use. This article is for educational and informational purposes only. Nothing here constitutes medical advice. Consult a qualified physician before considering any peptide use.
The half-life of AOD-9604 is not established. This means dosing once daily, ideally morning fasted is typical to maintain stable levels. The half-life directly affects how long AOD-9604 remains active and influences optimal injection timing.
What Is the Half-Life of AOD-9604?
The half-life of AOD-9604 is not established. This is the time it takes for blood concentration to drop by 50% after administration.
Understanding half-life is essential for designing effective dosing protocols — it determines how often you need to administer AOD-9604 to maintain therapeutic blood levels.
What Does AOD-9604's Half-Life Mean for Dosing?
With a half-life of not established, AOD-9604 requires dosing once daily, ideally morning fasted to maintain stable levels. The standard dosage of 250-1000 mcg daily via subcutaneous injection accounts for this pharmacokinetic profile.
After approximately 4-5 half-lives, AOD-9604 reaches steady-state concentration — the point where the amount being absorbed equals the amount being eliminated. For AOD-9604, this occurs within the first few days of consistent dosing.
When Is the Best Time to Inject AOD-9604?
Optimal timing depends on your research goals. A half-life of not established means peak blood levels occur shortly after injection and decline predictably.
Common timing approaches: morning injection for daytime activity, pre-bed injection for overnight effects, or split dosing (once daily, ideally morning fasted) for more stable levels throughout the day.
How Does AOD-9604's Half-Life Compare to Similar Peptides?
AOD-9604 is a Lipolytic peptide, GH fragment analog. Its half-life of not established positions it with a longer duration of action compared to some alternatives in this class.
Shorter half-lives require more frequent dosing but allow for more precise control. Longer half-lives are more convenient but carry risk of accumulation.
Calculate Your AOD-9604 Dose
Use our free peptide dosing calculator to get exact reconstitution math and syringe units for AOD-9604.
Open Calculator →Bottom Line: AOD-9604 Half-Life and Dosing
AOD-9604 has a half-life of not established, supporting the standard protocol of 250-1000 mcg daily dosed once daily, ideally morning fasted over 12-24 weeks.
Read our AOD-9604 dosage guide for complete protocol details.
Complete Guide
AOD-9604: The Fat Loss Peptide Fragment
Related Reading
- AOD-9604 Dosage Guide
- AOD-9604 Benefits
- AOD-9604 Side Effects
- AOD-9604 Stacking Guide
- AOD-9604 Cycle Guide
- AOD-9604 Research
Research-Grade Sourcing
If you're going to research AOD-9604, source matters. These are the suppliers WolveStack has vetted for purity and third-party testing.
Frequently Asked Questions
What is AOD-9604?
AOD-9604 (Fragment 177-191 of Human Growth Hormone (modified)) is a Lipolytic peptide, GH fragment analog. Synthetic analog of human GH fragment 177-191, engineered to selectively activate lipolysis without systemic GH effects. It is researched for fat loss, increased fat oxidation, improved body composition, joint health support, no IGF-1 elevation.
What is the recommended AOD-9604 dosage?
Common dosages: 250-1000 mcg daily administered once daily, ideally morning fasted via subcutaneous injection. Cycle length: 12-24 weeks. Half-life: not established. Use our peptide calculator for exact reconstitution math.
What are the side effects of AOD-9604?
Well-tolerated across 900+ participants in clinical trials. Minimal adverse effects — potential mild headache, dizziness, or injection site reactions. One of the safest peptides in terms of documented human tolerability.
Is AOD-9604 safe?
AOD-9604 has shown a favorable safety profile in research. Not FDA-approved. Development discontinued 2007. Available as research chemical. All research should follow appropriate safety protocols.